Teva To Continue Selling Generic Vicoprofen After Losing Vs. Abbott At Federal Circuit
Teva said the U.S. Court of Appeals for the Federal Circuit has vacated a September 2002 summary judgment which invalidated the patent protecting vicoprofen.
The district court had ruled that the U.S. patent was invalid as obvious, but the Federal Circuit disagreed with the lower court.
“Although the prior art appears to suggest combining an opioid, such as hydrocodone,...
To view the full article, register now.